172282-50-7 Usage
Description
Pantoprazole Impurity 11 is a chemical compound associated with the pharmaceutical drug Pantoprazole, which is a proton pump inhibitor used to treat various gastrointestinal conditions. It is an impurity that may be present during the manufacturing process of Pantoprazole and is characterized by its specific chemical structure and properties.
Uses
Used in Pharmaceutical Industry:
Pantoprazole Impurity 11 is used as a reference material for the development and validation of analytical methods in the pharmaceutical industry. It helps in ensuring the quality, safety, and efficacy of Pantoprazole by providing a benchmark for impurity testing and quantification.
Additionally, it may be used in the research and development of new drugs or drug formulations, as understanding the properties and effects of impurities can contribute to the improvement of drug design and synthesis processes.
Used in Quality Control:
Pantoprazole Impurity 11 is used as a quality control substance in the pharmaceutical industry to assess the performance of analytical instruments and methods. It aids in the detection and quantification of impurities in Pantoprazole, ensuring that the drug meets the required purity standards and regulatory guidelines.
Check Digit Verification of cas no
The CAS Registry Mumber 172282-50-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,2,2,8 and 2 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 172282-50:
(8*1)+(7*7)+(6*2)+(5*2)+(4*8)+(3*2)+(2*5)+(1*0)=127
127 % 10 = 7
So 172282-50-7 is a valid CAS Registry Number.
172282-50-7Relevant articles and documents
Preparation method of 4- polyfluoro methoxy O-phenylenediamine (by machine translation)
-
Paragraph 0013, (2020/01/03)
The method disclosed by the invention 4 - is characterized in that the aminophenol, and the alkali :(1) are reacted at a mole ratio of the 1:0.8-1.5, 20-40 °C compound 0.1-24h with the halogen, and, the halogen compound in the solvent to 1:1.0-3.0,20-120 °C, 0.01-20Mpa react with 1-72h. 1-72h the 4 - 1:0.8-30.0 ammonia solution ;(2)4 - or the halogen compound at a mole ratio of the compound of the 1:0.2 - 2.5 amino phenol, 30-80 °C with 0.1-24h;(3)4 - the halogen and the halogen compound in the solvent 0.1-10%, 50-200 °C, 0.01-10Mpa: 4 . (by machine translation)
Diversified synthesis of novel quinoline and dibenzo thiazepine derivatives using known active intermediates
Sharada,Satyanarayana Reddy,Sammaiah,Sumalatha
, p. 7959 - 7966 (2013/09/23)
The novel drug development to control resisting infections in conventional drug therapy is a need of today. Few antiulcer relative derivatives developed by approaching convergent synthesis. The derivatives synthesized successfully are dibenzo thiazepine-pyridine (SLN11-SLN15) and benzimidazole-hydroquinoline based derivatives (SLN16-SLN20). It involved the coupling through microwave, sonication and conventional techniques at final step. The efficient technology identified as sonication technique basically time and yield. The reported compounds were structural characterized by elemental analysis and spectral studies such as 1H, 13C NMR and MS.